Single-cell and spatial multi-omics reveal estrogen-mediated vaginal wall microenvironment remodeling and a perivascular reparative niche in postmenopausal pelvic organ prolapse - Report - MDSpire

Single-cell and spatial multi-omics reveal estrogen-mediated vaginal wall microenvironment remodeling and a perivascular reparative niche in postmenopausal pelvic organ prolapse

  • By

  • Lin Wang

  • Lingyun Wei

  • Mengyu Geng

  • Shuyu Wang

  • Wenzhen Wang

  • Nan Jia

  • Xiaochun Liu

  • July 3, 2026

  • 0 min

Share

Clinical Report: Estrogen-Driven Remodeling of Vaginal Wall in POP

Overview

This study reveals that estrogen induces selective expansion and spatial redistribution of fibroblasts in the vaginal wall, forming a structured perivascular niche.

Background

Pelvic organ prolapse (POP) is a prevalent condition affecting many postmenopausal women, significantly impacting their quality of life. Local estrogen therapy is commonly used to manage urogenital symptoms associated with menopause, yet its clinical outcomes vary. Understanding the mechanisms by which estrogen acts on the vaginal wall is crucial for developing effective treatments for POP.

Data Highlights

No numerical data or trial data provided in the article.

Key Findings

  • Estrogen drives the selective expansion of HAS1+ fibroblasts in the vaginal wall.
  • Fibroblasts aggregate with pericytes to form a structured perivascular niche.
  • This spatial co-localization enhances fibroblast-pericyte crosstalk.
  • Estrogen activates multiple pro-repair signaling cascades within the vaginal wall microenvironment.
  • The study highlights the importance of spatial organization in tissue repair mechanisms.

Clinical Implications

Further experimental validation is necessary to confirm these mechanisms and their clinical relevance.

Conclusion

This research provides a foundational understanding of how estrogen remodels the vaginal wall microenvironment.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. Pelvic Organ Prolapse | ACOG, ACOG, 2024 -- Practice Bulletin
  6. Recommendations | NICE, NICE, 2019 -- Guidance on POP
  7. The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause, Journal of Urology, 2025 -- Guideline
  8. Perioperative Vaginal Estrogen as Adjunct to Native Tissue Vaginal Apical Prolapse Repair: A Randomized Clinical Trial, PubMed, 2023 -- Study
  9. Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial, The BMJ, 2025 -- Study
  10. ACOG Practice Bulletin on Pelvic Organ Prolapse
  11. NICE Guidance on Pelvic Organ Prolapse
  12. AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause
  13. Perioperative Vaginal Estrogen as Adjunct to Native Tissue Vaginal Apical Prolapse Repair: A Randomized Clinical Trial - PubMed
  14. Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial | The BMJ
  15. Does preoperative locally applied estrogen treatment facilitate prolapse‐associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse? A randomised controlled double‐masked, placebo‐controlled, multicentre study - PMC
  16. Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women - PMC
  17. The Role of Vaginal Oestrogen Therapy in Postmenopausal Women With Pelvic Organ Prolapse: Does It Have Any Impact on Perioperative Outcomes? A Systematic Review of Randomised Controlled Trials - Sicilia - BJOG: An International Journal of Obstetrics & Gynaecology - Wiley Online Library
  18. Effectiveness of hormones in postmenopausal pelvic floor dysfunction—International Urogynecology Association research and development—committee opinion

Original Source(s)

Related Content